Get started
Author

Jon Bjoern

Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
2013 · Trine Zeeberg Iversen, Lotte Engell-Noerregaard, et al. · Clinical Cancer Research · 125
Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab
2015 · Jon Bjoern, Nikolaj Juul Nitschke, et al. · OncoImmunology · 83
PDF
Safety, immune and clinical responses in metastatic melanoma patients vaccinated with a long peptide derived from indoleamine 2,3-dioxygenase in combination with ipilimumab
2016 · Jon Bjoern, Trine Zeeberg Iversen, et al. · Cytotherapy · 53
Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
2017 · Jon Bjoern, Rikke Lyngaa, et al. · Oncotarget · 31
PDF
Indoleamine 2,3-dioxygenase and survivin peptide vaccine combined with temozolomide in metastatic melanoma
2017 · Nikolaj Juul Nitschke, Jon Bjoern, et al. · Stem Cell Investigation · 23
PDF
Changes in Peripheral Blood Level of Regulatory T cells in Patients with Malignant Melanoma During Treatment with Dendritic Cell Vaccination and Low‐dose IL‐2
2010 · J. Bjoern, M. K. Brimnes, et al. · Scandinavian Journal of Immunology · 17
PDF
Therapeutic Vaccination against A Modified Minimal Survivin Epitope Induces Functional CD 4 T Cells That Recognize Survivin‐Expressing Cells
2016 · N. J. Nitschke, J. Bjoern, et al. · Scandinavian Journal of Immunology · 7
PDF
Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase
2013 · Trine Z Iversen, Lotte Engell-Noerregaard, et al. · Journal for ImmunoTherapy of Cancer · 6
PDF
Effects of ipilimumab on expanded tumor-infiltrating lymphocytes in patients with stage IV malignant melanoma.
2014 · Jon Bjoern, Marco Donia, et al. · Journal of Clinical Oncology · 4
Correction: Influence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma
2018 · Jon Bjoern, Rikke Lyngaa, et al. · Oncotarget · 1
PDF
Phase I study of peptide vaccine targeting indeolamine 2,3 dioxygenase in metastatic lung cancer patients.
2013 · Trine Zeeberg Iversen, Lotte Engell-Noerregaard, et al. · Journal of Clinical Oncology · 1
Data from Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
2023 · Trine Zeeberg Iversen, Lotte Engell-Noerregaard, et al.
Data from Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
2023 · Trine Zeeberg Iversen, Lotte Engell-Noerregaard, et al.
Supplementary figure from Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
2023 · Trine Zeeberg Iversen, Lotte Engell-Noerregaard, et al.
PDF
Supplementary figure from Long-lasting Disease Stabilization in the Absence of Toxicity in Metastatic Lung Cancer Patients Vaccinated with an Epitope Derived from Indoleamine 2,3 Dioxygenase
2023 · Trine Zeeberg Iversen, Lotte Engell-Noerregaard, et al.
Inferior Outcomes for Older Patients in the Adolescent and Young Adult (AYA) Population with Burkitt Lymphoma Treated with Intensive Immunochemotherapy: An International Study of 108 Patients
2019 · Fredrik Ellin, Knut B. Smeland, et al. · Blood
Works count: 16
Citation count: 351
H-index: 7
I10-index: 6
Year
Topic
Type